» Articles » PMID: 38453949

NFκB and NLRP3/NLRC4 Inflammasomes Regulate Differentiation, Activation and Functional Properties of Monocytes in Response to Distinct SARS-CoV-2 Proteins

Abstract

Increased recruitment of transitional and non-classical monocytes in the lung during SARS-CoV-2 infection is associated with COVID-19 severity. However, whether specific innate sensors mediate the activation or differentiation of monocytes in response to different SARS-CoV-2 proteins remain poorly characterized. Here, we show that SARS-CoV-2 Spike 1 but not nucleoprotein induce differentiation of monocytes into transitional or non-classical subsets from both peripheral blood and COVID-19 bronchoalveolar lavage samples in a NFκB-dependent manner, but this process does not require inflammasome activation. However, NLRP3 and NLRC4 differentially regulated CD86 expression in monocytes in response to Spike 1 and Nucleoprotein, respectively. Moreover, monocytes exposed to Spike 1 induce significantly higher proportions of Th1 and Th17 CD4 + T cells. In contrast, monocytes exposed to Nucleoprotein reduce the degranulation of CD8 + T cells from severe COVID-19 patients. Our study provides insights in the differential impact of innate sensors in regulating monocytes in response to different SARS-CoV-2 proteins, which might be useful to better understand COVID-19 immunopathology and identify therapeutic targets.

Citing Articles

Helicobacter pylori infection promotes M1 macrophage polarization and gastric inflammation by activation of NLRP3 inflammasome via TNF/TNFR1 axis.

Fei X, Chen S, Li L, Xu X, Wang H, Ke H Cell Commun Signal. 2025; 23(1):6.

PMID: 39762835 PMC: 11705855. DOI: 10.1186/s12964-024-02017-7.


COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation.

Rodriguez-Ubreva J, Calafell-Segura J, Calvillo C, Keller B, Ciudad L, Handfield L Nat Commun. 2024; 15(1):10344.

PMID: 39609471 PMC: 11605083. DOI: 10.1038/s41467-024-54732-x.


Inflammasome activity regulation by PUFA metabolites.

Atalay Ekiner S, Gegotek A, Skrzydlewska E Front Immunol. 2024; 15:1452749.

PMID: 39290706 PMC: 11405227. DOI: 10.3389/fimmu.2024.1452749.

References
1.
Ruan Q, Yang K, Wang W, Jiang L, Song J . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846-848. PMC: 7080116. DOI: 10.1007/s00134-020-05991-x. View

2.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

3.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

4.
Makarova Y, Ryabkova V, Salukhov V, Sagun B, Korovin A, Churilov L . Atherosclerosis, Cardiovascular Disorders and COVID-19: Comorbid Pathogenesis. Diagnostics (Basel). 2023; 13(3). PMC: 9914751. DOI: 10.3390/diagnostics13030478. View

5.
Deng S, Peng H . Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. J Clin Med. 2020; 9(2). PMC: 7074453. DOI: 10.3390/jcm9020575. View